The partnership will give customers easy access to GLP-1 class drugs and other anti-obesity medications.
The company, spun out of MIT and backed by Define Ventures, GV and Flare Capital Partners, was founded by veteran AI and clinical leaders from MIT, Harvard, Microsoft and Google.
The collaboration aims to integrate Lamar Health's specialty medication-focused AI platform into Uptiv Health's operations.
The companies said the aim of the partnership is to address the pressure pathologists face due to the global shortage of pathologists and the increasing number of cancer patients.
The company's SimpleSense wearable will ingest glucose data from the Dexcom G7 continuous glucose monitor system.
The company says it partnered with child psychologists to develop an online safety platform for individuals and families to protect children from "technology's negative effects."
The company will use the funds to invest in technology and expand into new market segments.
The company will use the funds to expand its presence across the U.S. health market and enhance its AI technology and platform.
Evinova's digital platform will give study sites the ability to monitor patients enrolled in Quantum Leap's clinical trial for interstitial lung disease.
